Charles Schwab Investment Management Inc Acrivon Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 113,840 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,840
Previous 116,253 2.08%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
N/A
-2,413 Reduced 2.08%
113,840 $0
Q3 2024

Nov 12, 2024
SELL
N/A
-27,705 Reduced 19.25%
116,253 $0
Q2 2024

Aug 12, 2024
BUY
N/A
66,576 Added 86.04%
143,958 $0
Q1 2024

May 08, 2024
BUY
N/A
8,881 Added 12.96%
77,382 $0
Q4 2023

Feb 06, 2024
BUY
N/A
840 Added 1.24%
68,501 $0
Q3 2023

Nov 08, 2023
BUY
N/A
6,703 Added 11.0%
67,661 $0
Q2 2023

Aug 09, 2023
BUY
N/A
2,749 Added 4.72%
60,958 $0
Q1 2023

May 11, 2023
BUY
N/A
58,209 New
58,209 $0

Others Institutions Holding ACRV

# of Institutions
60
Shares Held
23.3M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email